Last reviewed · How we verify

multiple doses of sucrose

Sheba Medical Center · Phase 1 active Small molecule

multiple doses of sucrose is a Small molecule drug developed by Sheba Medical Center. It is currently in Phase 1 development. Also known as: sucrose 24%.

At a glance

Generic namemultiple doses of sucrose
Also known assucrose 24%
SponsorSheba Medical Center
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about multiple doses of sucrose

What is multiple doses of sucrose?

multiple doses of sucrose is a Small molecule drug developed by Sheba Medical Center.

Who makes multiple doses of sucrose?

multiple doses of sucrose is developed by Sheba Medical Center (see full Sheba Medical Center pipeline at /company/sheba-medical-center).

Is multiple doses of sucrose also known as anything else?

multiple doses of sucrose is also known as sucrose 24%.

What development phase is multiple doses of sucrose in?

multiple doses of sucrose is in Phase 1.

Related